1. European Medicines Agency 2005 Document reference: Doc.Ref.:EMEA/590296/2008 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000572/WC500036776.pdf
2. International Veterinary Academy of Pain Management (IVAPM) http://iavpm.org
3. Therapeutic Goods Administration 2011 Australian Public Assessment Report of Tapentadol. Table 1: Minimal efficacious doses in various animal pain models 9 https://www.tga.gov.au/sites/default/files/auspar-palexia-sr.pdf
4. Young , K. 2008 FDA Center for Drug Evaluation and Research: Tapentadol, Application No. 22-304 60 62 https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022304s000_MedR_P1.pdf
5. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs;Abbo;Vet Ther,2008